Medicare Enrolled
Dr. John Graham, M.D.
Hematology & Oncology · Canfield, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Graham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Graham?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Graham
Dr. John Graham is a hematology & oncology specialist in Canfield, OH, with 14 years of NPI registration. Based on federal Medicare data, Dr. Graham performed 49,322 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Graham received a total of $16,586 from 99 pharmaceutical and/or device companies across 829 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Graham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 10% volume in OH
$16,586 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗49,322
Medicare services
Top 10% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
26,200 | $1 | $3 |
| Denosumab injection (Prolia/Xgeva) | 9,000 | $8 | $11 |
| Iron infusion (Monoferric) | 2,600 | $17 | $35 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,659 | $0 | $0 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,305 | $8 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,268 | $8 | $33 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,225 | $10 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
622 | $60 | $105 |
| Anti-nausea injection (Aloxi/palonosetron) | 610 | $1 | $25 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
608 | $12 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
452 | $89 | $175 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
360 | $95 | $275 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
307 | $12 | $35 |
| Iron level test | 306 | $6 | $48 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
305 | $13 | $45 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
277 | $15 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
248 | $10 | $45 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
246 | $1 | $2 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
216 | $62 | $110 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
175 | $46 | $130 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
154 | $48 | $110 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 141 | $20 | $60 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
134 | $22 | $85 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
133 | $134 | $210 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
130 | $10 | $55 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
126 | $21 | $85 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 90 | $14 | $25 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 77 | $345 | $900 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
67 | $103 | $225 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
64 | $19 | $55 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
49 | $137 | $310 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
39 | $61 | $125 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
38 | $2 | $40 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $71 | $180 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
29 | $15 | $50 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
16 | $15 | $45 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $118 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.6% high complexity
78.8% medium
13.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,586
Total received (2018-2024)
Avg $2,369/year across 7 years
Top 22% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
829
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,395
2023
$3,125
2022
$2,586
2021
$2,565
2020
$1,638
2019
$2,730
2018
$548
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$277
ASD Specialty Healthcare, LLC
$241
Novartis Pharmaceuticals Corporation
$235
GENZYME CORPORATION
$233
ABBVIE INC.
$158
AstraZeneca Pharmaceuticals LP
$155
Celgene Corporation
$144
PFIZER INC.
$136
Janssen Biotech, Inc.
$131
Takeda Pharmaceuticals U.S.A., Inc.
$120
Eisai Inc.
$110
Blueprint Medicines Corporation
$97
Merck Sharp & Dohme LLC
$94
Daiichi Sankyo Inc.
$82
Pharmacosmos Therapeutics Inc.
$81
Lilly USA, LLC
$80
Amgen Inc.
$76
Astellas Pharma US Inc
$72
Tempus AI, Inc
$71
GlaxoSmithKline, LLC.
$66
Exelixis Inc.
$65
SOBI, INC
$58
Genmab U.S., Inc.
$58
Deciphera Pharmaceuticals Inc.
$37
JAZZ PHARMACEUTICALS INC.
$35
Kyowa Kirin, Inc.
$35
Acrotech Biopharma Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Genentech USA, Inc.
$25
Tolmar, Inc.
$25
Biocon Biologics Inc
$24
Stemline Therapeutics Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
Sumitomo Pharma America, Inc.
$23
Incyte Corporation
$23
Octapharma USA, Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$22
Aveo Pharmaceuticals, Inc.
$21
Agios Pharmaceuticals, Inc.
$20
United Therapeutics Corporation
$19
TAIHO ONCOLOGY, INC.
$18
Ipsen Biopharmaceuticals, Inc
$17
ARRAY BIOPHARMA INC
$17
Verity Pharmaceuticals Inc.
$16
Apellis Pharmaceuticals, Inc.
$16
Karyopharm Therapeutics Inc.
$15
Rigel Pharmaceuticals, Inc.
$11
Top 3 companies account for 22.2% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,244
Novartis Pharmaceuticals Corporation
$992
Amgen Inc.
$811
AstraZeneca Pharmaceuticals LP
$751
ASD Specialty Healthcare, LLC
$684
GENZYME CORPORATION
$649
Celgene Corporation
$571
PFIZER INC.
$534
Merck Sharp & Dohme Corporation
$478
Eisai Inc.
$414
Merck Sharp & Dohme LLC
$396
Exelixis Inc.
$390
Astellas Pharma US Inc
$381
Genentech USA, Inc.
$366
Daiichi Sankyo Inc.
$366
Takeda Pharmaceuticals U.S.A., Inc.
$334
Pharmacyclics LLC, An AbbVie Company
$325
GlaxoSmithKline, LLC.
$304
Janssen Biotech, Inc.
$289
ASD SPECIALTY HEALTHCARE, LLC
$282
Incyte Corporation
$276
Regeneron Healthcare Solutions, Inc.
$263
Boehringer Ingelheim Pharmaceuticals, Inc.
$262
Blueprint Medicines Corporation
$257
Seagen Inc.
$251
Lilly USA, LLC
$216
ABBVIE INC.
$207
EMD Serono, Inc.
$193
Pharmacyclics LLC, an AbbVie Company
$174
Bayer HealthCare Pharmaceuticals Inc.
$155
JAZZ PHARMACEUTICALS INC.
$153
EISAI INC.
$153
Dendreon Pharmaceuticals LLC
$148
ImmunoGen, Inc.
$147
Deciphera Pharmaceuticals Inc.
$131
Rigel Pharmaceuticals, Inc.
$114
ARRAY BIOPHARMA INC
$111
Genmab U.S., Inc.
$111
Kyowa Kirin, Inc.
$102
BeiGene USA, Inc.
$101
SOBI, INC
$93
Emmaus Medical, Inc.
$92
Karyopharm Therapeutics Inc.
$91
Epizyme, Inc.,
$89
Clovis Oncology, Inc.
$82
Pharmacosmos Therapeutics Inc.
$81
Mylan Institutional Inc.
$81
EUSA Pharma (US) LLC
$81
Lexicon Pharmaceuticals, Inc.
$78
MorphoSys, US Inc.
$73
Ipsen Biopharmaceuticals, Inc
$72
Tempus AI, Inc
$71
AbbVie, Inc.
$65
Octapharma USA, Inc.
$64
CTI BioPharma Corp.
$63
Acrotech Biopharma LLC
$60
Bayer Healthcare Pharmaceuticals Inc.
$59
Kite Pharma, Inc.
$57
AVEO Pharmaceuticals, Inc.
$49
Dova Pharmaceuticals
$47
Biocon Biologics Inc
$46
Helsinn Therapeutics (U.S.), Inc.
$45
Heron Therapeutics, Inc.
$45
Myriad Genetic Laboratories, Inc.
$44
Jazz Pharmaceuticals Inc.
$42
Stemline Therapeutics Inc.
$41
Seattle Genetics, Inc.
$40
Mirati Therapeutics, Inc.
$38
Global Blood Therapeutics, Inc.
$38
G1 Therapeutics, Inc.
$37
Apellis Pharmaceuticals, Inc.
$35
Secura Bio, Inc.
$34
Aveo Pharmaceuticals, Inc.
$34
Acrotech Biopharma Inc.
$32
Puma Biotechnology, Inc.
$32
Taiho Oncology, Inc.
$30
Gilead Sciences, Inc.
$27
AMAG Pharmaceuticals, Inc.
$26
PUMA BIOTECHNOLOGY, INC.
$25
Tolmar, Inc.
$25
Acceleron Pharma, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
Sumitomo Pharma America, Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$22
AbbVie Inc.
$22
Agios Pharmaceuticals, Inc.
$20
TG THERAPEUTICS, INC.
$19
Janssen Pharmaceuticals, Inc
$19
United Therapeutics Corporation
$19
TAIHO ONCOLOGY, INC.
$18
TerSera Therapeutics LLC
$17
TOLMAR Pharmaceuticals, Inc.
$17
Verity Pharmaceuticals Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
TESARO, Inc.
$14
Myovant Sciences Inc.
$13
Aurobindo Pharma USA, Inc.
$12
Teva Pharmaceuticals USA, Inc.
$12
MEDIVATION FIELD SOLUTIONS LLC
$12
Top 3 companies account for 18.4% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALTUVIIIO · ALUNBRIG · AUGTYRO · AYVAKIT · Alecensa · Avastin · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Creon · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EXKIVITY · Elahere · Empaveli · Endari · Enhertu · Epkinly · FARESTON · FARYDAK · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · Fulphila · GAMMAGARD · GAVRETO · GAZYVA · GILOTRIF · HEMADY · HYQVIA · Halaven · Hulio · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · Inrebic · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SYLVANT · Stivarga · Sustol · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEPMETKO · TIVDAK · TUKYSA · TYVASO · Tavalisse · Tecentriq · Tibsovo · Tivdak · Trelstar · Trodelvy · Truxima · Turalio · UKONIQ · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
19
County median income
$55,576
Nearest hospital to ZIP centroid (approximate)
HMHP ST ELIZABETH BOARDMAN HEALTH CENTER
5.5 mi
5.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Graham is a mixed practice specialist, with above-average Medicare volume (top 10% in OH).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Graham experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Graham performed 26,200 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Graham receive payments from pharmaceutical companies?
Yes. Dr. Graham received a total of $16,586 from 99 companies across 829 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Graham's costs compare to other hematology & oncology specialists in Canfield?
Dr. Graham's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Graham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Canfield
Browse hematology & oncology specialists in Canfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology